Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nabilone for Non-motor Symptoms in Parkinson's Disease
NCT03769896Phase 2Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Oct 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nabilone in Parkinson's disease (PD), sponsored by Medical University of Innsbruck. Started Oct 2017; status: completed.
02
Drugs
nabilone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03769896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03769896.